Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

NMTC

NeuroOne Medical Technol... (NMTC)

NeuroOne Medical Technologies Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NMTC
DateHeureSourceTitreSymboleSociété
14/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/05/202422h00GlobeNewswire Inc.NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
10/05/202420h43GlobeNewswire Inc.NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14NASDAQ:NMTCNeuroOne Medical Technologies Corporation
10/04/202415h00GlobeNewswire Inc.NeuroOne® CEO Dave Rosa Featured on Bloomberg TechnologyNASDAQ:NMTCNeuroOne Medical Technologies Corporation
09/04/202415h05GlobeNewswire Inc.NeuroOne® Announces First Implant of OneRF™ Ablation ElectrodesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
04/04/202415h00GlobeNewswire Inc.NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.NASDAQ:NMTCNeuroOne Medical Technologies Corporation
26/03/202414h00GlobeNewswire Inc.NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/03/202418h00GlobeNewswire Inc.NeuroOne® to Participate in the 36th Annual Roth ConferenceNASDAQ:NMTCNeuroOne Medical Technologies Corporation
04/03/202420h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
23/02/202423h10GlobeNewswire Inc.NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NMTCNeuroOne Medical Technologies Corporation
13/02/202422h00GlobeNewswire Inc.NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/02/202421h30GlobeNewswire Inc.NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13NASDAQ:NMTCNeuroOne Medical Technologies Corporation
31/01/202422h09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NMTCNeuroOne Medical Technologies Corporation
29/01/202415h02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NMTCNeuroOne Medical Technologies Corporation
29/01/202415h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NMTCNeuroOne Medical Technologies Corporation
05/01/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
21/12/202315h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
15/12/202322h39Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/12/202322h15GlobeNewswire Inc.NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
11/12/202314h00GlobeNewswire Inc.NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
07/12/202322h30GlobeNewswire Inc.NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14NASDAQ:NMTCNeuroOne Medical Technologies Corporation
16/11/202314h00GlobeNewswire Inc.NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural ProbeNASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/11/202323h15GlobeNewswire Inc.NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NMTCNeuroOne Medical Technologies Corporation
07/11/202314h00GlobeNewswire Inc.NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
13/10/202315h30GlobeNewswire Inc.NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023NASDAQ:NMTCNeuroOne Medical Technologies Corporation
06/09/202322h00GlobeNewswire Inc.NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/08/202322h00GlobeNewswire Inc.NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/08/202322h00GlobeNewswire Inc.NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14NASDAQ:NMTCNeuroOne Medical Technologies Corporation
25/07/202314h00GlobeNewswire Inc.NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common StockNASDAQ:NMTCNeuroOne Medical Technologies Corporation
 Showing the most relevant articles for your search:NASDAQ:NMTC

Dernières Valeurs Consultées

Delayed Upgrade Clock